PPARγ/NF-κB γ /NF- κ B axis contributes to cold-induced resolution of experimental colitis and preservation of intestinal barrier

被引:1
作者
Di, Yuzhu [1 ]
Li, Hui [1 ]
Yang, Jia [2 ]
Feng, Minghao [2 ]
Wang, Shuang [1 ]
Li, Wanying [1 ]
Wang, Xiuqing [1 ]
Zhu, Yuxin [1 ]
Shi, Yan [3 ]
Feng, Rennan [4 ,5 ]
Qu, Bo [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Harbin 150000, Peoples R China
[2] Harbin Med Univ, Coll Bioinformat Sci & Technol, Dept Syst Biol, Harbin 150086, Peoples R China
[3] Harbin Inst Technol, Lab Space Environm & Phys Sci, Harbin 150028, Peoples R China
[4] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150081, Heilongjiang, Peoples R China
[5] Harbin Med Univ, Sch Publ Hlth, Key Lab Precis Nutr & Hlth, Minist Educ, Harbin 150081, Heilongjiang, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2024年 / 1870卷 / 07期
基金
中国国家自然科学基金;
关键词
Cold exposure; IBD; PPAR gamma signaling; Multi-omics; Inflammation; ACTIVATED RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; EXPRESSION; IBD; ROSIGLITAZONE;
D O I
10.1016/j.bbadis.2024.167326
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Environmental stress is a significant contributor to the development of inflammatory bowel disease (IBD). The involvement of temperature stimulation in the development of IBD remains uncertain. Our preliminary statistical data suggest that the prevalence of IBD is slightly lower in colder regions compared to non- cold regions. The observation indicates that temperature changes may play a key role in the occurrence and progression of IBD. Here, we hypothesized that cold stress has a protective effect on IBD. Methods: The cold exposure model for mice was placed in a constant temperature and humidity chamber, maintained at a temperature of 4 degrees C. Colitis models were induced in the mice using TNBS or DSS. To promote the detection methods more clinically, fluorescence confocal endoscopy was used to observe the mucosal micro- circulation status of the colon in the live model. Changes in the colonic wall of the mice were detected using 9.4 T Magnetic Resonance Imaging (MRI) imaging and in vivo fluorescence imaging. Hematoxylin and eosin (H&E) &E) and Immunofluorescence (IF) staining confirmed the pathological alterations in the colons of sacrificed mice. Molecular changes at the protein level were assessed through Western blotting and Enzyme-Linked Immunosorbent Assay (ELISA) assays. RNA sequencing (RNA-seq) and metabolomics (n n = 18) were jointly analyzed to investigate the biological changes in the colon of mice treated by cold exposure. Results: Cold exposure decreased the pathologic and disease activity index scores in a mouse model. Endomicroscopy revealed that cold exposure preserved colonic mucosal microcirculation, and 9.4 T MRI imaging revealed alleviation of intestinal wall thickness. In addition, the expression of the TLR4 and P-P65 - P65 proteins was downregulated and epithelial cell junctions were strengthened after cold exposure. Intriguingly, we found that cold exposure reversed the decrease in ZO-1 and occludin protein levels in dextran sulfate sodium (DSS)- and trinitrobenzenesulfonic acid-induced colitis mouse models. Multi-omics analysis revealed the biological landscape of DSS-induced colitis under cold exposure and identified that the peroxisome proliferator-activated receptor (PPAR) signaling pathway mediates the effects of cold on colitis. Subsequent administration of rosiglitazone (PPAR agonist) enhanced the protective effect of cold exposure on colitis, whereas GW9662 (PPAR antagonist) administration mitigated these protective effects. Overall, cold exposure ameliorated the progression of mouse colitis through the PPAR gamma/NF-kappa B signaling axis and preserved the intestinal mucosal barrier. Conclusion: Our study provides a mechanistic link between intestinal inflammation and cold exposure, providing a theoretical framework for understanding the differences in the prevalence of IBD between the colder regions and non-cold regions, and offering new insights into IBD therapy.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Bifidobacterium lactis Inhibits NF-κB in Intestinal Epithelial Cells and Prevents Acute Colitis and Colitis-associated Colon Cancer in Mice
    Kim, Seung Won
    Kim, Hee Man
    Yang, Kyoung Min
    Kim, Sun-Ah
    Kim, Sung-Kyu
    An, Min Ji
    Park, Jae Jun
    Lee, Sang Kil
    Kim, Toe Il
    Kim, Won Ho
    Cheon, Jae Hee
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (09) : 1514 - 1525
  • [32] PPARγ inhibits NF-κB-dependent transcriptional activation in skeletal muscle
    Remels, A. H. V.
    Langen, R. C. J.
    Gosker, H. R.
    Russell, A. P.
    Spaapen, F.
    Voncken, J. W.
    Schrauwen, P.
    Schols, A. M. W. J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (01): : E174 - E183
  • [33] Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-κB p65
    Zhou, Yishan
    Zhong, Bingling
    Min, Xiangjing
    Hou, Ying
    Lin, Ligen
    Wu, Qin
    Shi, Jingshan
    Chen, Xiuping
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5861 - 5870
  • [34] Amorfrutin A inhibits TNF-α-induced NF-κB activation and NF-κB-regulated target gene products
    Shi, Hui
    Ma, Juan
    Mi, Chunliu
    Li, Jing
    Wang, Fei
    Lee, Jung Joon
    Jin, Xuejun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 56 - 62
  • [35] Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice
    Colombo, Barbara B.
    Fattori, Victor
    Guazelli, Carla F. S.
    Zaninelli, Tiago H.
    Carvalho, Thacyana T.
    Ferraz, Camila R.
    Bussmann, Allan J. C.
    Ruiz-Miyazawa, Kenji W.
    Baracat, Marcela M.
    Casagrande, Rubia
    Verri, Waldiceu A., Jr.
    INFLAMMATION, 2018, 41 (04) : 1276 - 1289
  • [36] Lancemaside A ameliorates colitis by inhibiting NF-κB activation in TNBS-induced colitis mice
    Joh, Eun-Ha
    Lee, In-Ah
    Han, Sang-Jun
    Chae, SunJu
    Kim, Dong-Hyun
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (05) : 545 - 551
  • [37] Lancemaside A ameliorates colitis by inhibiting NF-κB activation in TNBS-induced colitis mice
    Eun-Ha Joh
    In-Ah Lee
    Sang-Jun Han
    SunJu Chae
    Dong-Hyun Kim
    International Journal of Colorectal Disease, 2010, 25 : 545 - 551
  • [38] Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/ PPAR-γ/NF-κB/ROS signaling pathways
    Cao, Shen
    Lv, Baojiang
    Tai, Yi
    Zuo, Hong Xiang
    Xing, Yue
    Surh, Young-Joon
    Li, Ming Yue
    Ma, Juan
    Jin, Xuejun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 496
  • [39] Theabrownins prevents DSS-induced colitis via modulating PPAR-γ and NF-κB signaling pathways in mice
    Cai, Yunjie
    Huang, Yina
    Qiu, Liang
    Mi, Xuan
    Wang, Yu
    Tao, Xueying
    Wei, Hua
    JOURNAL OF FUNCTIONAL FOODS, 2023, 109
  • [40] The sinomenine enteric-coated microspheres suppressed the TLR/NF-κB signaling in DSS-induced experimental colitis
    Xiong, Huifang
    Tian, Liang
    Zhao, Zihan
    Chen, Shuping
    Zhao, Qiaoyun
    Hong, Junbo
    Xie, Yong
    Zhou, Nanjin
    Fu, Yingjun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 50 : 251 - 262